Effect of truncated glucagon-like peptide 1 on cAMP in rat gastric glands and HGT-1 human gastric cancer cells

FEBS Lett. 1988 Aug 15;236(1):119-22. doi: 10.1016/0014-5793(88)80297-7.

Abstract

We tested the truncated 7-37 glucagon-like peptide 1 (TGLP-1), a naturally occurring porcine intestinal peptide, and other members of the glucagon family, including pancreatic glucagon (G-29), GLP-1 and GLP-2 for their ability to activate the cAMP generating system in rat gastric glands and HGT-1 human gastric cancer cells. In rat fundic glands, TGLP-1 was about 100 times more potent (EC50 = 2.8 X 10(-9) M) than GLP-1 of G-29, and 10 times more potent than G-29 in the HGT-1 cell line. Our results support the notion that TGLP-1 plays a direct role in the regulation of acid secretion in rat and human gastric mucosa.

MeSH terms

  • Animals
  • Cyclic AMP / metabolism*
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / metabolism
  • Glucagon / pharmacology*
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Male
  • Peptides / pharmacology*
  • Protein Precursors / pharmacology
  • Rats
  • Receptors, Cell Surface / metabolism
  • Receptors, Glucagon*
  • Stomach Neoplasms
  • Tumor Cells, Cultured

Substances

  • GLP1R protein, human
  • Glp1r protein, rat
  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptide-1 Receptor
  • Peptides
  • Protein Precursors
  • Receptors, Cell Surface
  • Receptors, Glucagon
  • Glucagon-Like Peptide 1
  • Glucagon
  • Cyclic AMP